Cyclobenzaprine Hydrochloride

CAS 6202-23-9 8 current records 7 historicalSmall Molecule

Who holds supplier records for Cyclobenzaprine Hydrochloride? 8 organisations hold a current record for Cyclobenzaprine Hydrochloride: an active US FDA Type II Drug Master File. A further 7 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (5), Spain (2) and Italy (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Cyclobenzaprine Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/cyclobenzaprine-hydrochloride

Reading the evidence

  • 8 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    5 of the 8 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (8)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Cyclobenzaprine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Cyclobenzaprine Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (7)

Organisations whose Type II DMFs for Cyclobenzaprine Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 7 historical records
  • India · Inactive DMF 23063 · filed Aug 2009
  • Poland · Inactive DMF 18317 · filed Apr 2005
  • SIFAVITOR SRL
    Inactive DMF 9510 · filed Jan 1992
  • Switzerland · Inactive DMF 8101 · filed Jun 1989
  • SUMIKA FINE CHEMICALS CO LTD
    Inactive DMF 8065 · filed Apr 1989
  • Finland · Inactive DMF 7759 · filed Oct 1988
  • GANES CHEMICALS INC PENNSVILLE DIV
    Inactive DMF 5810 · filed May 1985

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Cyclobenzaprine Hydrochloride is a muscle relaxant used to relieve skeletal muscle spasms and is commonly prescribed in conjunction with rest and physical therapy. It acts on the central nervous system to produce its muscle relaxant effects.

Chemical identity

IUPAC name
N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)propan-1-amine;hydrochloride
Canonical SMILES
CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31.Cl
InChIKey
VXEAYBOGHINOKW-UHFFFAOYSA-N
Synonyms
Flexeril API, amrix, cyclobenzaprine hcl, flexeril, nsc-169900, nsc-173379, nsc-78206, tonmya

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Muscle Relaxant
Physiologic effect
Centrally-mediated Muscle Relaxation

Therapeutic areas

MusculoskeletonPainNeurology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Cyclobenzaprine Hydrochloride?

8 organisations hold an active US FDA Type II Drug Master File or a CEP for Cyclobenzaprine Hydrochloride: DERIVADOS QUIMICOS SAU (Spain), Dipharma Francis Srl (Italy), Hetero Drugs Limited (India), JUBILANT BIOSYS LTD (India), MEDICHEM SA (Spain), R.L.FINE CHEM PRIVATE LIMITED (India), Unichem Laboratories Ltd. (India) and VASUDHA PHARMA CHEM LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Cyclobenzaprine Hydrochloride Drug Master Files are active?

DERIVADOS QUIMICOS SAU (DMF 23521), Dipharma Francis Srl (DMF 5864), Hetero Drugs Limited (DMF 21392), JUBILANT BIOSYS LTD (DMF 24719), MEDICHEM SA (DMF 5827), R.L.FINE CHEM PRIVATE LIMITED (DMF 33147), Unichem Laboratories Ltd. (DMF 34654) and VASUDHA PHARMA CHEM LTD (DMF 21779). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Cyclobenzaprine Hydrochloride records mean?

7 organisations have only inactive Type II DMFs for Cyclobenzaprine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Cyclobenzaprine Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Cyclobenzaprine Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.